| Republic of Korea | Turchia | Austria | |
| Physiotherapy | da $3,000 | da $50 | da $600 |
| Stem cell therapy for ankylosing spondylitis | - | da $7,000 | da $20,000 |
| Biological therapy | - | da $5,500 | da $20,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi dei trattamenti di Ankylosing spondylitis. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Ankylosing spondylitis e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Ankylosing spondylitis.
Dr. Ahn Tae Hoon trained at Montreal Heart Institute and leads the Cardiovascular Center at Naeun Hospital.
Director of the Orthopedic Center at Naeun Hospital – specializes in joint disorders and arthroscopic surgery.
Prof. Heo is a leading neurologist in South Korea specializing in epilepsy treatment. He is the head of the Neurology Department at Yonsei Severance Hospital and a graduate of Yonsei University College of Medicine. He is a member of The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
Dr. Kang Shin-Hyuk is a prominent Neurosurgeon in Seoul, South Korea with over 25+ years of experience in the field. His research interests include brain and spinal tumor, degenerative spinal disease, cervical vertebrae diseases, tumor diseases and injury in the vertebrae and spinal cord, and more. Dr. Kang Shin-Hyuk has published several presentations on spinal and brain tumors and other related topics in seminars and journals, and has won several awards in the field. He has demonstrated that hypoxia-induced Stat3 activity contributes to HIF-1, VEGF, MMP-2, and Twist expression in human glioblastoma.